The Role of the Polycystic Ovary Syndrome Susceptibility Locus D19S884 Allele 8 in Maternal Glycemia and Fetal Size

Overview

Journal J Clin Endocrinol Metab

Publisher Oxford University Press

Specialty Endocrinology

Date 2010 May 7

PMID 20444918

Citations 4

Authors

C M Ackerman

L P Lowe

H Lee

F Chen

E Hughes

P Cholod

A R Dyer

M G Hayes

B E Metzger

W L Lowe

M Urbanek

Affiliations

Soon will be listed here.

Abstract

Context: The high incidence of insulin resistance, type 2 diabetes, and metabolic syndrome in Western societies and their impact on quality of life emphasize the importance of identifying underlying susceptibility loci for metabolic diseases. The polycystic ovary syndrome (PCOS) susceptibility locus D19S884 allele 8 (A8) is associated with measures of insulin resistance, beta-cell dysfunction, and other metabolic phenotypes in PCOS families. We now investigate the role of D19S884 A8 in pregnancy.

Objective: Using the multiethnic Hyperglycemia and Adverse Pregnancy Outcome cohort, we assessed the associations of D19S884 A8 with measures of maternal glycemia and fetal size.

Design: We tested for association of maternal D19S884 A8 with maternal outcomes (fasting, 1-h, and 2-h plasma glucose, and fasting and 1-h C-peptide from an oral glucose tolerance test) and fetal and maternal D19S884 A8 with fetal outcomes (birth weight, length, head circumference, sum of skin folds, fat mass, cord C-peptide, and 2-h neonatal plasma glucose).

Subjects: We analyzed 4424 Caucasian mothers and 3347 offspring of northern European ancestry, 1957 Thai mothers and 2089 offspring from Bangkok, 1208 Afro-Caribbean mothers and 1209 offspring from Barbados, and 774 Hispanic mothers and 762 offspring from Bellflower, California.

Results: After adjusting for confounding variables and multiple testing, neither maternal nor fetal D19S884 A8 showed significant evidence for association with any of the outcomes tested.

Conclusions: The PCOS susceptibility locus, D19S884 A8, is not a major factor contributing to glycemia during pregnancy or fetal size in a general obstetric population.

Citing Articles

Associations between testosterone, estradiol, and androgen receptor genotype with amygdala subregions in adolescents.

Campbell C, Mezher A, Michael Tyszka J, Nagel B, Eckel S, Herting M Psychoneuroendocrinology. 2021; 137:105604.

PMID: 34971856 PMC: 8925279. DOI: 10.1016/j.psyneuen.2021.105604.

Obstetric complications in women with IVF conceived pregnancies and polycystic ovarian syndrome.

Tandulwadkar S, Lodha P, Mangeshikar N J Hum Reprod Sci. 2014; 7(1):13-8.

PMID: 24829525 PMC: 4018791. DOI: 10.4103/0974-1208.130802.

Genetics of the polycystic ovary syndrome.

Kosova G, Urbanek M Mol Cell Endocrinol. 2012; 373(1-2):29-38.

PMID: 23079471 PMC: 3609918. DOI: 10.1016/j.mce.2012.10.009.

Ethnic variation in allele distribution of the androgen receptor (AR) (CAG)n repeat.

Ackerman C, Lowe L, Lee H, Hayes M, Dyer A, Metzger B J Androl. 2011; 33(2):210-5.

PMID: 21597087 PMC: 3833274. DOI: 10.2164/jandrol.111.013391.

References

Forsen T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C, Barker D . The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med. 2000; 133(3):176-82. DOI: 10.7326/0003-4819-133-3-200008010-00008. View

Sam S, Legro R, Essah P, Apridonidze T, Dunaif A . Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome. Proc Natl Acad Sci U S A. 2006; 103(18):7030-5. PMC: 1459013. DOI: 10.1073/pnas.0602025103. View

Legro R, Castracane V, Kauffman R . Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv. 2004; 59(2):141-54. DOI: 10.1097/01.OGX.0000109523.25076.E2. View

Sam S, Legro R, Bentley-Lewis R, Dunaif A . Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005; 90(8):4797-802. PMC: 4428585. DOI: 10.1210/jc.2004-2217. View

Villuendas G, Escobar-Morreale H, Tosi F, Sancho J, Moghetti P, San Millan J . Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome. Fertil Steril. 2003; 79(1):219-20. DOI: 10.1016/s0015-0282(02)04570-3. View

Urbanek M, Sam S, Legro R, Dunaif A . Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. J Clin Endocrinol Metab. 2007; 92(11):4191-8. DOI: 10.1210/jc.2007-0761. View

Skol A, Scott L, Abecasis G, Boehnke M . Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet. 2006; 38(2):209-13. DOI: 10.1038/ng1706. View

Ibanez L, Potau N, Francois I, de Zegher F . Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab. 1998; 83(10):3558-62. DOI: 10.1210/jcem.83.10.5205. View

Azziz R, Woods K, Reyna R, Key T, Knochenhauer E, Yildiz B . The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004; 89(6):2745-9. DOI: 10.1210/jc.2003-032046. View

10.

Carlsen S, Jacobsen G, Romundstad P . Maternal testosterone levels during pregnancy are associated with offspring size at birth. Eur J Endocrinol. 2006; 155(2):365-70. DOI: 10.1530/eje.1.02200. View

11.

Tucci S, FUTTERWEIT W, Concepcion E, Greenberg D, Villanueva R, Davies T . Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus. J Clin Endocrinol Metab. 2001; 86(1):446-9. DOI: 10.1210/jcem.86.1.7274. View

12.

Lo J, Feigenbaum S, Escobar G, Yang J, Crites Y, Ferrara A . Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study. Diabetes Care. 2006; 29(8):1915-7. DOI: 10.2337/dc06-0877. View

13.

Sir-Petermann T, Hitchsfeld C, Maliqueo M, Codner E, Echiburu B, Gazitua R . Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod. 2005; 20(8):2122-6. DOI: 10.1093/humrep/dei009. View

14.

. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes. 2008; 58(2):453-9. PMC: 2628620. DOI: 10.2337/db08-1112. View

15.

Newsome C, Shiell A, Fall C, Phillips D, Shier R, Law C . Is birth weight related to later glucose and insulin metabolism?--A systematic review. Diabet Med. 2003; 20(5):339-48. DOI: 10.1046/j.1464-5491.2003.00871.x. View

16.

Sam S, Dunaif A . Polycystic ovary syndrome: syndrome XX?. Trends Endocrinol Metab. 2003; 14(8):365-70. DOI: 10.1016/j.tem.2003.08.002. View

17.

Pfeiffer A, Drewes C, Schatz H . Elevated plasma levels of transforming growth factor-beta 1 in NIDDM. Diabetes Care. 1996; 19(10):1113-7. DOI: 10.2337/diacare.19.10.1113. View

18.

Prodoehl M, Hatzirodos N, Irving-Rodgers H, Zhao Z, Painter J, Hickey T . Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries. Mol Hum Reprod. 2009; 15(12):829-41. PMC: 2776474. DOI: 10.1093/molehr/gap072. View

19.

Colilla S, Cox N, Ehrmann D . Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab. 2001; 86(5):2027-31. DOI: 10.1210/jcem.86.5.7518. View

20.

Mi J, Law C, Zhang K, Osmond C, Stein C, Barker D . Effects of infant birthweight and maternal body mass index in pregnancy on components of the insulin resistance syndrome in China. Ann Intern Med. 2000; 132(4):253-60. DOI: 10.7326/0003-4819-132-4-200002150-00002. View